Preservation of Alloreactive and Antiviral Immunity After Switch to Belatacept-Based Regimen After Kidney Transplantation.

被引:0
|
作者
Schaenman, J. [1 ]
Korin, Y. [2 ]
Sidwell, T. [2 ]
Groysberg, V. [2 ]
Gadzhyan, J. [1 ]
Lum, E. [1 ]
Reddy, U. [1 ]
Huang, E. [1 ]
Pham, T. [1 ]
Danovitch, G. [1 ]
Reed, E. [2 ]
Bunnapradist, S. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
D141
引用
收藏
页码:744 / 744
页数:1
相关论文
共 50 条
  • [41] MAINTENANCE IMMUNOSUPPESSIVE THERAPY WITH BELATACEPT AFTER HEART AND KIDNEY TRANSPLANTATION
    Barten, Markus
    Thaiss, Friedrich
    TRANSPLANT INTERNATIONAL, 2017, 30 : 469 - 469
  • [42] Arterial Stiffness in Kidney Transplantation: Belatacept Versus Calcineurin Inhibitor Based Regimen
    Melilli, E.
    Bestard, O.
    Cruzado, J.
    Gelpi, R.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 285 - 286
  • [43] Conversion to Belatacept After Kidney Transplantation Does Not Alter Immunophenotype
    Matz, M.
    Fabritius, K.
    Lorkowski, C.
    Liu, J.
    Brakemeier, S.
    Unterwalder, N.
    Neumayer, H. -H.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [44] Association between Two Polymorphisms in Immunity Genes and Cytomegalovirus Reactivation after Kidney Transplantation.
    Hoffmann, Thomas W.
    Halimi, Jean-Michel
    Buechler, Mathias
    Velge-Roussel, Florence
    Al-Najjar, Azmi
    Marliere, Jean-Frederic
    Lebranchu, Yvon
    Baron, Christophe
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 569 - 569
  • [45] Outcomes after Simultaneous Kidney Pancreas versus Pancreas after Kidney Transplantation.
    Parajuli, S.
    Arunachalam, A.
    Swanson, K.
    Aziz, F.
    Garg, N.
    Redfield, R.
    Kaufman, D.
    Djamali, A.
    Odorico, J.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 488 - 488
  • [46] Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal regimen after living kidney transplantation.
    Huh, W
    Lee, K
    Lee, K
    Kim, S
    Joh, J
    Oh, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P26 - P26
  • [47] Psychotic Disorders and Outcomes after Kidney Transplantation.
    Molnar, M.
    Eason, J.
    Gaipov, A.
    Talwar, M.
    Potukuchi, P.
    Kalantar-Zadeh, K.
    Kovesdy, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 695 - 696
  • [48] Thrombocytopenia after Alemtuzumab Induction in Kidney Transplantation.
    Chan, K.
    Tanna, A.
    Charif, R.
    Cairns, T.
    Duncan, N.
    Galliford, J.
    Kumar, N.
    McLean, A.
    Palmer, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 431 - 431
  • [49] Restless legs syndrome after kidney transplantation.
    Molnar, MZ
    Kovacs, AZ
    Ambrus, C
    Remport, A
    Pap, J
    Novak, M
    Mucsi, I
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 915A - 915A
  • [50] Renal Resistance Indices After Kidney Transplantation.
    Boran, M.
    Tola, M.
    Boran, M.
    Boran, E.
    TRANSPLANTATION, 2014, 98 : 571 - 572